14-day Premium Trial Subscription Try For FreeGet Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CTMX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

CytomX Therapeutics stock upgraded to Buy Candidate.
(Updated on Dec 01, 2023)


Buy candidate since Dec 01, 2023 PDF
The CytomX Therapeutics stock price gained 1.44% on the last trading day (Friday, 1st Dec 2023), rising from $1.39 to $1.41. During the last trading day the stock fluctuated 5.15% from a day low at $1.36 to a day high of $1.43. The price has risen in 6 of the last 10 days and is up by 9.3% over the past 2 weeks. Volume fell on the last day by -36 thousand shares and in total, 204 thousand shares were bought and sold for approximately $287.80 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

Given the current short-term trend, the stock is expected to fall -4.73% during the next 3 months and, with a 90% probability hold a price between $0.99 and $1.34 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

CTMX Signals & Forecast

The CytomX Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.35 and $1.26. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, October 27, 2023, and so far it has risen 31.78%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Get your hands on a piece of history – invest in multi-million dollar paintings from $10k with Masterworks.

Support, Risk & Stop-loss for CytomX Therapeutics stock

CytomX Therapeutics finds support from accumulated volume at $1.38 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0700 between high and low, or 5.15%. For the last week the stock has had daily average volatility of 5.06%.

Our recommended stop-loss: $1.37 (-3.06%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 24 days ago.)

Trading Expectations (CTMX) For The Upcoming Trading Day Of Monday 4th

For the upcoming trading day on Monday, 4th we expect CytomX Therapeutics to open at $1.40, and during the day (based on 14 day Average True Range), to move between $1.33 and $1.49, which gives a possible trading interval of +/-$0.0784 (+/-5.56%) up or down from last closing price. If CytomX Therapeutics takes out the full calculated possible swing range there will be an estimated 11.12% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.42 (0.71%) than the support at $1.38 (2.13%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is CytomX Therapeutics stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 4.795 Open Broker Account

Buy Candidate Upgraded

Predicted Opening Price for CytomX Therapeutics of Monday, December 4, 2023

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Fair opening price December 4, 2023 Current price
$1.40 $1.41 (Overvalued)

Remember To Visit Our YouTube Channel


Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.47 4.26 %
R2 1.44 2.36 %
R1 1.43 1.19 %
Current price: 1.41
Support S1 1.37 -2.61 %
S2 1.36 -3.78 %
S3 1.33 -5.67 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 1.42 0.709 %
Current price 1.41
Support S1 1.38 -2.13%
S2 1.33 -5.67%
S3 1.28 -9.22%
What is the symbol for CytomX Therapeutics Stock and on which exchange is it traded?
The symbol for CytomX Therapeutics is CTMX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell CytomX Therapeutics Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

How to buy CytomX Therapeutics Stock?
CytomX Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy CytomX Therapeutics Stock.

What's the current price of CytomX Therapeutics Stock?
As of the end of day on the 2023-12-01, the price of an CytomX Therapeutics (CTMX) share was $1.41.

What is the 52-week high and low for CytomX Therapeutics Stock?
The 52-week high for CytomX Therapeutics Stock is $3.02 and the 52-week low is $1.04.

What is the market capitalization of CytomX Therapeutics Stock?
As of the 2023-12-01, the market capitalization of CytomX Therapeutics is 93.115M.

When is the next earnings date for CytomX Therapeutics?
The upcoming earnings date for CytomX Therapeutics is 2024-03-25 00:00:00.

Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT